posteditor

posteditor

Theradaptive Announces Final Patient Enrolled in RESTORE Feasibility Study Evaluating OsteoAdapt® DE in Dental Procedures

B Study enrollment completion marks critical milestone in advancing bone regeneration for dental reconstruction using Theradaptive’s targeted therapeutic platform FREDERICK, Md., April 23, 2026 /PRNewswire/ — Theradaptive, Inc., a clinical-stage biotechnology company pioneering targeted protein therapeutics for tissue regeneration, today…